Cochrane Clinical Answers
Cochrane Clinical Answers (CCAs) provide a readable, digestible, clinically focused entry point to rigorous research from Cochrane systematic reviews. They are designed to be actionable and to inform decision making at the point of care and have been added to relevant sections of the main Best Practice text.
- How does targeted immunotherapy compare with standard targeted therapy for people with previously treated metastatic renal cell carcinoma?
Use of this content is subject to our disclaimer